menu
    • menu

    Company profile for Rubicon Research

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rubicon Research is a pioneer Drug Delivery Technology company based in India with significant experience in the field of formulation development. Rubicon has developed many differentiated products which are protected by patents and are available for out licensing. Rubicon also provides a full spectrum of development services from pre-formulation to registration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rubicon Researchindia-flag Flag
    Country
    Country
    India
    Address
    Address
    221,Annexe Building ,Goregaon-Mulund Link Road,
    Telephone
    Telephone
    91 226 141 4000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.rubicon.co.in/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rubin Research’s Generics Clonazepam Receives Approval in US
    Rubin Research’s Generics Clonazepam Receives Approval in US

    21 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216988

    FDA
    21 May 2026
    Share Share
    Rubicon Enters Indian CNS Sector With Rs 175.92 Cr Arinna
    Rubicon Enters Indian CNS Sector With Rs 175.92 Cr Arinna

    16 Apr 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/rubicon-forays-into-indias-cns-segment-with-rs-17592-crore-arinna-buy-19755

    INDPHARMAPOST
    16 Apr 2026
    Share Share
    Rubicon Research Acquires 85% Stake In Arinna Lifesciences
    Rubicon Research Acquires 85% Stake In Arinna Lifesciences

    15 Apr 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/rubicon-research-acquires-85-stake-in-arinna-lifesciences/

    EXPRESSPHARMA
    15 Apr 2026
    Share Share
    Rubin Research’s Generics Ibuprofen Receives Approval in US
    Rubin Research’s Generics Ibuprofen Receives Approval in US

    05 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220239

    FDA
    05 Mar 2026
    Share Share
    Rubin Research’s Generics Cetirizine HCl Receives Approval in US
    Rubin Research’s Generics Cetirizine HCl Receives Approval in US

    25 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220335

    FDA
    25 Feb 2026
    Share Share
    Rubin’s Generics Rimegepant Receives Tentative Approval in US
    Rubin’s Generics Rimegepant Receives Tentative Approval in US

    14 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219440

    FDA
    14 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Rubicon Research Private Limited and get a quotation

    Rubicon Research Private Limited is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find Dextromethorphan bulk with DMF offered by Rubicon Research Private Limited

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search